Gilead Sciences Inc buy Deutsche Bank Aktiengesellschaft
Start price
18.02.25
/
50%
€99.69
Target price
18.02.26
€114.86
Performance (%)
29.52%
End price
19.02.26
€129.12
Summary
This prediction ended on 19.02.26 with a price of €129.12. The prediction had a final performance of 29.52%. A total of €3.16 was paid as dividends for this prediction. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Gilead Sciences Inc | -1.662% | -1.662% | 15.986% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $120.00 price target on the stock, up previously from $80.00.
Ratings data for GILD provided by MarketBeat
In the thread Trading Gilead Sciences Inc
Die von Deutsche_Bank_Aktien gewählte maximale Laufzeit wurde überschritten